Skip to main content

Research Repository

Advanced Search

All Outputs (2)

CDK12 inhibition reduces abnormalities in cells from patients with myotonic dystrophy and in a mouse model (2020)
Journal Article
Ketley, A., Wojciechowska, M., Ghidelli-Disse, S., Bamborough, P., Ghosh, T. K., Morato, M. L., …Brook, J. D. (2020). CDK12 inhibition reduces abnormalities in cells from patients with myotonic dystrophy and in a mouse model. Science Translational Medicine, 12(541), Article eaaz2415. https://doi.org/10.1126/scitranslmed.aaz2415

Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Myotonic dystrophy type 1 (DM1) is an RNA-based disease with no current treatment.... Read More about CDK12 inhibition reduces abnormalities in cells from patients with myotonic dystrophy and in a mouse model.

Neurovascular structures in human vastus lateralis muscle and the ideal biopsy site (2018)
Journal Article
Chen, X., Abbey, S., Bharmal, A., Harris, S., Hudson, E., Krinner, L., …Billeter, R. (2019). Neurovascular structures in human vastus lateralis muscle and the ideal biopsy site. Scandinavian Journal of Medicine and Science in Sports, 29(4), 504-514. https://doi.org/10.1111/sms.13369

A density model of neurovascular structures was generated from 28 human vastus lateralis muscles isolated from embalmed cadavers. The intramuscular portion of arteries, veins and nerves was dissected, traced on transparencies and digitised before adj... Read More about Neurovascular structures in human vastus lateralis muscle and the ideal biopsy site.